WINDTREE THERAPEUTICS INC /DE/ Proceeds from Issuance of Private Placement
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Proceeds from Issuance of Private Placement of $4.12 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for the quarter ending 2024-12-31 was $195.00K.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for the quarter ending 2023-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for the quarter ending 2020-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for fiscal 2024 was $4.12M.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for fiscal 2023 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for fiscal 2019 was $22.98M, a 30.13% decline from fiscal 2018.
- WINDTREE THERAPEUTICS INC /DE/ proceeds from issuance of private placement for fiscal 2018 was $32.89M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2024-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $4.12M 10-K · filed 2025-04-15 | ||
| 2024-09-30 | $3.92M 10-Q · filed 2024-11-26 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-26 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $20.25M 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $20.25M 10-Q · filed 2020-08-14 | |||
| 2019-12-31 | $22.98M 10-K · filed 2021-03-29 | |||
| 2018-12-31 | $32.89M 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |